What is he best known for?
The fields of study he is best known for:
Naoki Mori spends much of his time researching Cancer research, T-cell leukemia, Leukemia, Molecular biology and Cell culture.
The Cancer research study combines topics in areas such as Cell cycle checkpoint, Apoptosis, Survivin, Carcinogenesis and Transfection.
Naoki Mori has researched T-cell leukemia in several fields, including T cell, Peripheral blood mononuclear cell, XIAP and Cyclin D2.
His research combines Virology and Leukemia.
His studies deal with areas such as Jurkat cells, Transcription factor, Gene and Promoter as well as Molecular biology.
His research integrates issues of In vitro, Helicobacter pylori and Matrix metalloproteinase in his study of Cell culture.
His most cited work include:
- Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells (278 citations)
- Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cells (267 citations)
- Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I–infected T-cell lines and primary adult T-cell leukemia cells (249 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Cancer research, Leukemia, T-cell leukemia, Molecular biology and Immunology.
The various areas that Naoki Mori examines in his Cancer research study include Cell culture, Cell cycle, Apoptosis, Survivin and Cell growth.
His Apoptosis research is multidisciplinary, incorporating elements of Cell and Fucoidan.
His Leukemia research includes elements of Carcinogenesis, T cell, Lymphoma and Virology.
His work carried out in the field of T-cell leukemia brings together such families of science as Cytokine and Interleukin 4.
His Molecular biology research is multidisciplinary, incorporating perspectives in Jurkat cells and Transcription factor, Gene expression, Gene, Transfection.
He most often published in these fields:
- Cancer research (47.00%)
- Leukemia (29.50%)
- T-cell leukemia (25.00%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer research (47.00%)
- Cell cycle (14.50%)
- IκB kinase (9.00%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Cell cycle, IκB kinase, Protein kinase B and Cell growth.
His research in Cancer research intersects with topics in Apoptosis, Survivin, Inhibitor of apoptosis, XIAP and Lymphoma.
His research investigates the connection between Apoptosis and topics such as Cell that intersect with issues in Intracellular and T cell.
Naoki Mori interconnects Molecular biology, Leukemia and Kinase in the investigation of issues within Cell cycle.
His Leukemia research incorporates elements of Oncogene and Interferon regulatory factors.
His studies deal with areas such as Viability assay and T-cell leukemia as well as Cell growth.
Between 2013 and 2021, his most popular works were:
- Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor. (11 citations)
- Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma (10 citations)
- Peridinin, a carotenoid, inhibits proliferation and survival of HTLV-1-infected T-cell lines. (10 citations)
In his most recent research, the most cited papers focused on:
Naoki Mori focuses on Cell cycle, Cancer research, Protein kinase B, IκB kinase and Inhibitor of apoptosis.
His Molecular biology research extends to Cell cycle, which is thematically connected.
His Molecular biology research integrates issues from Cell and Nuclear protein.
His research on Protein kinase B also deals with topics like
- Cyclin D1 which connect with Cell biology,
- Cell growth which is related to area like Viability assay, XIAP and Janus kinase.
The study incorporates disciplines such as Cyclin-dependent kinase 1 and Survivin in addition to IκB kinase.
His Apoptosis study incorporates themes from Extracellular, T cell and Leukemia, T-cell leukemia, Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
